Generic drug makers fight rule on health risk warnings

The proposed FDA regulation would close a legal loophole and allow patients to sue. An industry group predicts costs will soar, but others say it’s the right thing to do.

WASHINGTON — Companies that make generic drugs, the medications most Americans buy, are fighting to kill a proposed federal regulation that would require them for the first time to warn patients of all the known health risks of each drug they sell.
Nation –